Literature DB >> 25347779

Lactation and the use of biologic immunosuppressive medications.

Sarah J Witzel1.   

Abstract

Biologic medications are effective therapeutic options for treating autoimmune diseases, but information on their safety in lactation is still scarce. Autoimmune conditions occur frequently in women of childbearing age, creating difficult decisions regarding optimizing maternal health and supporting breastfeeding. Available data, in addition to the favorable pharmacokinetic properties of biologics, suggest that these medications are compatible with breastfeeding. A review of the available evidence and information is presented, as well as recommendations on counseling the nursing mother and her healthcare team to make informed decisions about maternal and infant care.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25347779      PMCID: PMC4267708          DOI: 10.1089/bfm.2014.0107

Source DB:  PubMed          Journal:  Breastfeed Med        ISSN: 1556-8253            Impact factor:   1.817


  8 in total

1.  The risks of not breastfeeding for mothers and infants.

Authors:  Alison Stuebe
Journal:  Rev Obstet Gynecol       Date:  2009

Review 2.  Breastfeeding, the immune response, and long-term health.

Authors:  Kelly M Jackson; Andrea M Nazar
Journal:  J Am Osteopath Assoc       Date:  2006-04

3.  Anti-TNF therapy and pregnancy outcomes in women with inflammatory arthritis.

Authors:  Evelyne Vinet; Christian Pineau; Caroline Gordon; Ann E Clarke; Sasha Bernatsky
Journal:  Expert Rev Clin Immunol       Date:  2009-01       Impact factor: 4.473

Review 4.  2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis.

Authors:  Jasvinder A Singh; Daniel E Furst; Aseem Bharat; Jeffrey R Curtis; Arthur F Kavanaugh; Joel M Kremer; Larry W Moreland; James O'Dell; Kevin L Winthrop; Timothy Beukelman; S Louis Bridges; W Winn Chatham; Harold E Paulus; Maria Suarez-Almazor; Claire Bombardier; Maxime Dougados; Dinesh Khanna; Charles M King; Amye L Leong; Eric L Matteson; John T Schousboe; Eileen Moynihan; Karen S Kolba; Archana Jain; Elizabeth R Volkmann; Harsh Agrawal; Sangmee Bae; Amy S Mudano; Nivedita M Patkar; Kenneth G Saag
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-05       Impact factor: 4.794

5.  The role of breastfeeding in postpartum disease activity in women with inflammatory bowel disease.

Authors:  Sunanda Kane; Nicole Lemieux
Journal:  Am J Gastroenterol       Date:  2005-01       Impact factor: 10.864

Review 6.  The influence of early life factors on the risk of developing rheumatoid arthritis.

Authors:  A N Colebatch; C J Edwards
Journal:  Clin Exp Immunol       Date:  2010-10-21       Impact factor: 4.330

7.  Breast-feeding and postpartum relapse in women with rheumatoid and inflammatory arthritis.

Authors:  J H Barrett; P Brennan; M Fiddler; A Silman
Journal:  Arthritis Rheum       Date:  2000-05

Review 8.  Management of inflammatory bowel disease in pregnancy.

Authors:  Susie W Ng; Uma Mahadevan
Journal:  Expert Rev Clin Immunol       Date:  2013-02       Impact factor: 4.473

  8 in total
  6 in total

Review 1.  Neuromyelitis optica spectrum disorders and pregnancy: therapeutic considerations.

Authors:  Yang Mao-Draayer; Sandra Thiel; Elizabeth A Mills; Tanuja Chitnis; Michelle Fabian; Ilana Katz Sand; M Isabel Leite; Sven Jarius; Kerstin Hellwig
Journal:  Nat Rev Neurol       Date:  2020-02-20       Impact factor: 42.937

2.  Fremanezumab in the treatment of migraines: evidence to date.

Authors:  Jennifer Robblee; Juliana VanderPluym
Journal:  J Pain Res       Date:  2019-08-22       Impact factor: 3.133

3.  The pre- and post-authorisation data published by the European medicines agency on the use of biologics during pregnancy and lactation.

Authors:  N Ghalandari; R J E M Dolhain; J M W Hazes; C L E Siezen; J W van der Laan; H J M J Crijns; E P van Puijenbroek; C J van der Woude
Journal:  Br J Clin Pharmacol       Date:  2020-01-23       Impact factor: 4.335

Review 4.  The use of biological drugs in psoriasis patients prior to pregnancy, during pregnancy and lactation: a review of current clinical guidelines.

Authors:  Witold Owczarek; Irena Walecka; Aleksandra Lesiak; Rafał Czajkowski; Adam Reich; Iwona Zerda; Joanna Narbutt
Journal:  Postepy Dermatol Alergol       Date:  2021-01-06       Impact factor: 1.837

5.  Atopic Dermatitis Treated Safely with Dupilumab during Pregnancy: A Case Report and Review of the Literature.

Authors:  Yolanka Lobo; Ruby C Lee; Lynda Spelman
Journal:  Case Rep Dermatol       Date:  2021-05-04

6.  Practical recommendations for systemic treatment in psoriasis according to age, pregnancy, metabolic syndrome, mental health, psoriasis subtype and treatment history (BETA-PSO: Belgian Evidence-based Treatment Advice in Psoriasis; part 1).

Authors:  J L W Lambert; S Segaert; P D Ghislain; T Hillary; A Nikkels; F Willaert; J Lambert; R Speeckaert
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-08       Impact factor: 6.166

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.